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Background: Frailty in the elderly increases their vulnerability and leads to a greater risk of adverse events.
According to various studies, the prevalence of the frailty syndrome in persons age 65 and over ranges between
3% and 37%, depending on age and sex. Walking speed in itself is considered a simple indicator of health status
and of survival in older persons. Detecting frailty in primary care consultations can help improve care of the elderly,
and walking speed may be an indicator that could facilitate the early diagnosis of frailty in primary care. The
objective of this work was to estimate frailty-syndrome prevalence and walking speed in an urban population aged
65 years and over, and to analyze the relationship between the two indicators from the perspective of early
diagnosis of frailty in the primary care setting.
Methods: Population cohort of persons age 65 and over from two urban neighborhoods in northern Madrid
(Spain). Cross-sectional analysis. Bivariate and multivariate analysis with binary logistic regression to study the
variables associated with frailty. Different cut-off points between 0.4 and 1.4 m/s were used to study walking speed
in this population. The relationship between frailty and walking speed was analyzed using likelihood ratios.
Results: The study sample comprised 1,327 individuals age 65 and older with mean age 75.41 ± 7.41 years; 53.4%
were women. Estimated frailty in the study population was 10.5% [95% CI: 8.9-12.3]. Frailty increased with age
(OR = 1.14; 95% CI: 1.10-1.19) and was associated with poor self-rated health (OR = 2.52; 95% CI: 1.43-4.44), number
of drugs prescribed (OR = 1.17; 95% CI: 1.08-1.26) and disability (OR = 6.58; 95% CI: 3.92-11.05). Walking speed less
than 0.8 m/s was found in 42.6% of cases and in 56.4% of persons age 75 and over. Walking speed greater than
0.9 m/s ruled out frailty in the study sample. Persons age 75 and older with walking speed <0.8 m/s are at
particularly high risk of frailty (32.1%).
Conclusions: Frailty-syndrome prevalence is high in persons aged 75 and over. Detection of walking speed
<0.8 m/s is a simple approach to the diagnosis of frailty in the primary care setting.
Keywords: Frailty in elderly, Walking speed, Early diagnosis, Primary careBackground
Frailty in elderly persons increases their vulnerability to
stress and results in an imbalance in the body’s homeo-
static reserve. Frailty weakens resistance to harmful
agents, thus leading to a greater risk of disability and im-
mobility, increased use of health services, and a higher
risk of death [1-3].* Correspondence: mcastell.gapm05@salud.madrid.org
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reproduction in any medium, provided the orTools that facilitate early detection of vulnerable indi-
viduals at increased risk of presenting adverse effects are
currently available. Different approaches to the definition
of frailty, especially those related to the different frailty
scales used, have made it difficult to reach a universal
consensus in this regard [3-6].
However, the frailty phenotype proposed by Fried in
2001 (unintentional weight loss, exhaustion, low physical
activity, slow walking speed and muscular weakness) [1],
has a broad consensus and is widely used in many coun-
tries, making it possible to implement preventive andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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frailty and its outcomes [1-3,7-9]. Its prevalence ranges
from 3-6% among those aged 65–70, to over 16% among
in persons aged 80 and over. Among men it has in-
creased from 2% in those aged 65–69 to 37% in men
aged 85 and over, and among women from 3% to 31%,
respectively [10]. In Spain, various working groups have
reported an overall prevalence of between 8.4% and
16.9% in persons aged 65 and over [11-14]. Part of this
variation is due to the lack of broad consensus about the
methodology used to measure this syndrome [5,13].
Several authors have stressed the role of the family phys-
ician in the detection and follow-up of older persons with
frailty. This role is important both for the possibility of de-
veloping therapeutic strategies that will prevent or reverse
the development of frailty, and for the opportunity to im-
plement interventions likely to prevent adverse outcomes
in frail patients, such as comprehensive geriatric assess-
ment to optimize the treatment of comorbid conditions
and promote early recognition of complications [13,15].
The widespread application in clinical practice of
Fried's criteria in the primary care setting is limited by
such aspects as the duration of the test, the need for
measuring instruments, the cut-off points for some cri-
teria that are not adapted to the study populations or
the family physician’s heavy workload, which makes it
difficult to conduct complex tests [5,15-18].
Together with frailty, slow walking speed is in itself a
widely used criterion in geriatric assessment, and has be-
come a good single estimator of frailty and its outcomes
[5,19]; some authors even consider it to be a vital indica-
tor [20]. A walking speed greater than 1.2 m/s suggests
high life expectancy, whereas speeds lower than 1 m/s
predict frailty and have been associated with disability,
hospitalization and decreased survival [19,20]. Other au-
thors establish the cut-off point at 0.8 m/s [21,22], while
the European consensus on sarcopenia establishes a
walking speed threshold of 0.8 m/s, and recommends
measurement of muscle mass for anyone below this cut-
off [23].
In Spain, primary care is the gateway to the public
healthcare system. Care of the elderly is a priority for
family physicians, given the high morbidity and frequent
use of the health system in this population group. After
age 75, the demand for health resources rises exponen-
tially, along with a great increase in frailty as a syndrome
[24]. Thus, the detection of frailty by the family phys-
ician can make an important contribution to the care of
patients nearing the end of their lives. Given the need to
optimize available resources, it is especially useful to
have cost-effective clinical tools to select those individ-
uals who can benefit most [15,16].
In this context, the present study aims to estimate
frailty-syndrome prevalence and walking speed in anurban population aged 65 years and over, and to analyze
the relationship between the two indicators from the
perspective of early diagnosis of frailty in the primary
care setting.
Methods
Design
Cross-sectional study based on population-based cohorts
of persons age 65 and over in two urban neighborhoods
of northern Madrid.
Methodology
A stratified random sample by sex and 5-year age groups
was obtained of individuals aged 65 and over living in two
neighborhoods in the north of Madrid (Peñagrande and
Cuatro Caminos) with a combined population of 9,200
people. The data source was the population register of
persons assigned to the primary health care centers in
these neighborhoods [25]. The final sample consists of
survivors of the Peñagrande Cohort (n = 814), created in
2008 [14], plus the random incorporation of 127 individ-
uals age 65–68 years in 2011 (included to maintain the
youngest age group), and a representative sample of 1,250
individuals from the population assigned to the Cuatro
Caminos health center in 2011 (Figure 1). We obtained
written informed consent for participation prior to the
interview and blood sampling. The project was approved
by the Clinical Research Ethics Committee in Hospital
Universitario La Paz, Madrid (HULP PI 1080).
Study variables
Frailty was evaluated according to the five criteria pro-
posed by Fried [1], following the original cut-off points,
with some adaptation: 1) Unintentional weight loss
(Shrinking) of ≥5% in the last year: If objective information
was not available, participants were asked the subjective
question “Have you lost more than 3 kg in the last
3 months?” 2) Low energy (Exhaustion): Based on ques-
tions from the Center for Epidemiologic Studies Depres-
sion Scale (CES-D): In the last week “I felt that everything
I did was an effort" and "I couldn´t get going. Those who
answered "frequently" or "always" to at least one of these
questions were considered to meet this criterion. 3) Weak-
ness: Grip strength in the dominant hand was measured
with a dynamometer (Jamar TM Hidraulic Hand Dyna-
mometer, Preston, Jackson, Missouri, EEUU) adjusted for
body mass index (BMI) according to the lowest quintile.
The cut-off points established were, for men: BMI ≤24
and grip strength <18.5 kg; 24 < BMI ≤28 and grip
strength <20 kg; BMI >28 and grip strength <22 kg; and
for women: BMI ≤29 and grip strength <11 Kg; BMI >29
and grip strength <12 kg. 4) Slowness: Calculated after
walking 3 meters, adjusted for sex and height, according
to Fried. The cut-off points for 3 meters were established
Age group 
(years)
Total
N=1,327
Men
N=619 (46.6%)
Women
N=708 (53.4%)
65-69 231 (17.4%) 101 (7.6%) 130 (9.8%)
70-74 292 (22.0%) 140 (10.6%) 152 (11.5 %)
75-79 283 (21.3%) 141 (10.6%) 142 (10.7 %)
80-84 268 (20.2%) 128 (9.6 %) 140 (10.6 %)
85-89 177 (13.3%) 79   (6%) 98 (7.4 %)
>= 90 76 (5.7 %) 30   (2.3 %) 46 (3.5 %)
1 Population not eligible: persons who had died, changed address or could not be located. 
STUDY POPULATION 
9,200  persons ≥65 years
“Peñagrande sample, 2011” 
(N=941)
(Peñagrande cohort = 814 plus 127 
persons  age 65-68)
Not eligible1
(N= 186)
Cuatro Caminos representative 
sample, 2011
(N=1,250)
Eligible
(N= 755)
Eligible
(N= 1005)
Not eligible1
(N= 245)
Refusals
(N=413)PARTICIPATED 
(N=1,327)
(Response rate 75.4%)
STUDY SAMPLE
N=1,760
Figure 1 Description of the sample and level of participation.
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to 0.65 m/s); height >1.73 cm and time ≥3.93 s (equivalent
to 0.76 m/s); and for women: height ≤1.59 cm and time
≥4.59 s (0.65 m/s); and height >1.59 cm and time ≥3.93 s
(0.76 m/s). 5) Low physical activity: Kilocalories (kcal)
expended per week were calculated based on the Longitu-
dinal Ageing Study Amsterdam (LASA) Physical Activity
Questionnaire (LAPAQ) [26], which is used to record
daily physical activity (walking, cycling, light and heavy
household chores and gardening) and physical exercise.
We maintained the cutoffs proposed by Fried: <383 kcal/
week for men and <270 kcal/week for women. Persons
who met at least three criteria were considered to be frail.
Walking speed, considered as a separate indicator, was
expressed in m/s and was obtained at the same time as
the slowness criterion was measured.
Independent variables. The sociodemographic vari-
ables measured were age, sex and marital status, number
of cohabitants (alone or accompanied), educational level(low if less than primary education; medium if primary
but not secondary education is completed; high if sec-
ondary or university level education), social status (low
status: agricultural worker, unskilled manual worker or
housewife with low educational level; medium status:
skilled manual worker, self-employed worker or house-
wife with medium or high educational level; high status:
managers, professionals), and socioeconomic level (total
household monthly income with two categories and cut-
off point at 600 euros (about $ 760). Health status was
measured by the following variables: Self-rated health,
which was defined based on the question “How is your
health in general?” (good if the answer was fair, good or
very good, and poor if the answer was poor or very
poor); Obesity (body mass index or BMI = weight in
kilograms/height in meters squared equal to or higher
than 30); Comorbidity, if there was presence of two or
more chronic diseases from a list of seven which in-
cludes: respiratory problems, heart disease, peripheral
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osteoporosis [27]; Cognitive decline, when the person
obtained a score of ≤24 on the Mini Mental State Exam-
ination (MMSE) validated for the Spanish population
[28]; Disability was considered to exist if the person
could not carry out at least one of the following basic ac-
tivities of daily living without help: walking across a
small room, bathing or showering, personal grooming
and getting dressed. Finally, medication used in the last
2 weeks for both acute and chronic diseases was
recorded. “Polypharmacy” was considered to be current
intake of 5 or more medications [29].
Statistical analysis
Frequencies and their 95% confidence intervals (95%
CI) were calculated for qualitative variables. The mean,
standard deviation and range were obtained for quanti-
tative variables. For the sole purpose of estimating data
in the reference population, the data were weighted by
assigning a specific weight (W) to each individual in the
sample, calculated as W =Nexp/Nobs, where Nobs is
the number of persons in a specific age/sex category in
the cohort, and Nexp is the number of persons of a spe-
cific sex and age in the north district of Madrid in 2010.
The prevalence of the frailty syndrome and walking
speed <0.8 m/s were calculated.
A bivariate analysis of frailty was made of the
sociodemographic and analytic variables, using the chi-
square test for categorical variables and Student’s t-test
for continuous variables. Statistical significance was con-
sidered to be a p-value <0.05. A multivariate analysis
with binary logistic regression was performed using
those variables that were associated with frailty in the
bivariate analysis with a p-value <0.10. A backward
stepwise procedure (back-step) was used to eliminate
variables in the model. Age and number of drugs were
introduced in the model as continuous variables after
verifying that they met the criterion of linearity. Each
factor was tested for interaction with age and sex. The
quality of the adjustment of the final model was assessed
using the Hosmer-Lemeshow goodness-of-fit test and
Nagelkerke’s coefficient of determination.
To study the characteristics and distribution of the in-
dicator walking speed in the study population, expressed
in meters/second to walk 3 meters, we selected different
cut-off points to classify each person as slow or not slow.
To cover the range of the different proposals in previous
publications [13,16] we used the following cut-off points:
0.4, 0.5, 0.6, 0.7, 0.8, 0.9 ,1.0, 1.1, 1.2, 1.3 and 1.4 m/s. To
analyze the relationship between the two indicators,
frailty and walking speed, we calculated the likelihood
ratios (LR) [30]. The LR + and LR- permit calculation of
the probability of frailty in patients with and without
slow walking speed (SWS), respectively. (LR + =% ofpeople with SWS who are frail /% of people with SWS
who are not frail; LR- =% people without SWS who are
frail /% people without SWS who are not frail).
The statistical analysis was performed using the soft-
ware package SPSS 19.0 for Windows.
Results
The study sample was made of up 1,327 individuals aged
65 years and over from the Madrid neighborhoods of
Peñagrande and Cuatro Caminos (Figure 1). The mean
age was 75.4 ± 7.4 (range: 65–104), and 53.4% were
women (708/1327).
Table 1 shows the distribution of the variables in the
study population. The frailty syndrome was present in
148 of 1,325 participants (frailty could not be measured
in two persons). The estimated population prevalence of
frailty was 10.5% [95% CI: 8.9-12.3] (data weighted by
age and sex). The prevalence was higher in women
(13.7%; 95% CI: 11.4-16.3) than in men (6.0%; 95% CI:
4.2- 8.4) and increased with age. The mean age of non-
frail individuals was 74.8 ± 6.8 while that of frail persons
was 85.9 ± 7.8.
The prevalence of frailty was 19.1% [95% CI: 16.2-
22.3] in persons age 75 and older and 1.4% [95% CI: 0.7-
2.7] in those under 75 years. Frailty was more frequent
in women, those aged 75 and over, widows, persons with
low educational level and socioeconomic status, poor
self-rated health, comorbidity, polymedication, disability
and cognitive decline (Table 1).
The multivariate analysis (Table 2) shows the associ-
ation between frailty and age (mean increase in odds of
frailty of 14% for each additional year of life). Frailty was
also associated with poor self-rated health (OR 2.52; 95%
CI: 1.43-4.44), number of drugs prescribed (17% increase
in odds of frailty for each additional drug), and disability
(OR 6.58; 95% CI: 3.92-11.05) after adjusting for all the
variables that showed an association in the bivariate
analysis.
Table 3 presents the distribution of walking speed in the
cohort by different cut-off points and its association with
frailty. A walking speed of less than 0.8 m/s was presented
by 42.6% of cases in the total sample, 99.3% of the frail
and 35.5% of the non-frail (LR + = 2.80 overall). In the
subpopulation of 75 and over the proportion of people
with walking speed <0.8 m/s was 56.4% (452/802) with a
LR + =2.10. A walking speed of less than 0.9 was found in
50.2% (100% of frail and 43.9% of non-frail individuals)
(LR + overall = 2.28 overall). In the subpopulation of 75
and over the proportion of people with walking speed
<0.9 m/s was 63.7% (511/802) with a LR + =1.78.
Frailty could be ruled out in 99.9% of individuals in
our sample aged 75 and over with walking speed
≥0.8 m/s (LR- = 0.01), and in 100% of those with walking
speed ≥0.9 m/s. Other cut-off points for walking speed
Table 1 Distribution of variables in the study population by frailty (data weighted by age and sex)
Total* Not frail** Frail**
P value***% (95% CI) % (95% CI) % (95% CI)
N = 1325 N = 1177 N = 148
Age
N = 1325<75 (N = 523) 48.5 (45.8- 51.3) 98.6 (97.3- 99.3) 1.4 (0.7- 2.7)
≥75 (N = 804) 51.5 (48.7-54.2) 80.9 (77.7- 83.7) 19.1 (16.2- 22.3)
Sex
<0.001Women (N = 708) 58.7 (55.9- 61.2) 86.3 (83.6- 88.6) 13.7 (11.4-16.3)
Men (N = 619) 41.3 (38.8- 44.1) 94.0 (91.6- 95.8) 6.0 (4.2-8.4)
Educational level
<0.001Complete primary (N = 835) 66.5 (63.8- 69.1) 92.9 (90.9- 94.5) 7.1 (5.5-9.0)
Incomplete primary (N = 449) 33.5 (30.9- 36.2) 85.1 (81.3- 88.2) 14.9 (11.7-18.7)
Marital status
<0.001
Married/with partner (N = 807) 60.3 (57.5- 62.8) 93.5 (91.5- 95.0) 6.5 (4.9-8.5)
Single/Separated (N = 163) 13.6 (11.7-15.5) 89.9 (84.3- 93.8) 10.1 (6.2-15.7)
Widowed (N = 352) 26.1 (23.9-28.8) 80.2 (75.5- 84.2) 19.8 (15.7-24.4)
Socioeconomic status
<0.001Hight-medium (N = 768) 59.0 (56.2- 61.6) 92.2 (90.1-93.9) 7.8 (6.0-9.9)
Low (N = 547) 41.0 (38.4- 43.8) 85.9 (82.6- 88.6) 14.1 (11.3-17.5)
Lives alone
0.133No (N = 1057) 79.8 (77.85- 81.9) 89.0 (86.9-90.7) 11.0 (9.2-13.1)
Yes (N = 263) 20.2 (18.2-22.6) 92.1 (88.0-94.9) 7.9 (5.1-11.9)
Self-rated health
<0.001Good (N = 1154) 89.7 (87.9- 91.3) 92.5 (90.8- 93.9) 7.5 (6.0-9.2)
Poor (N = 133) 10.3 (8.7-12.1) 69.7 (61.0- 77.2) 30.3 (22.8-39.0)
Comorbidity
<0.01<2 diseases (N = 866) 66.2 (63.6- 68.7) 91.4 (89.33- 93.2) 8.6 (6.8-10.7)
≥ 2 diseases (N = 461) 33.8 (31.3-36.4) 85.9 (82.2- 88.9) 14.1 (11.1-17.8)
BADL
<0.001Abled (N = 1170) 89.5 (87.6- 91.0) 95.5 (94.1- 96.6) 4.5 (3.42-5.9)
Disabled (N = 151) 10.5 (9.0-12.4) 38.1 (30.1- 46.8) 61.9 (53.2-69.9)
Use of medication
<0.001<5 medications (N = 561) 44.3 (41.6- 47.0) 95.1 (92.9- 96.6) 4.9 (3.4-7.1)
≥ 5 medications (N = 766) 55.7 (53.0-58.4) 85.1 (82.2- 87.5) 14.9 (12.5-17.7)
Cognitive decline
<0.001No (N = 1106) 84.4 (82.3- 86.3) 93.2 (91.5- 94.6) 6.8 (5.4-8.5)
Yes (N = 217) 15.6 (13.7-17.7) 70.9 (64.1- 76.9) 29.1 (23.2-36.1)
Obesity
<0.05
BMI ≤25 (N = 260) 20.4 (18.3- 22.8) 88.8 (84.1- 92.2) 11.2 (6.7-14.5)
BMI > 25 BMI < 30 (N = 594) 46.2 (43.4- 48.9) 93.7 (91.3- 95.4) 6.3 (4.6-8.7)
BMI ≥30 (N = 405) 33.4 (30.8-36.1) 93.1 (90.1- 95.3) 6.9 (4.7-9.8)
TOTAL 89.4 (87.5- 90.9) 10.5 (8.9- 12.3)
*% of each category within variable; **% frail/not frail; *** P-value: χ2 Test.
BADL Basic Activities of Daily Living, BMI Body Mass Index.
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Table 2 Multivariate analysis of frailty
Model I Model II
OR [95% CI] OR [95% CI]
Age a 1.21 [1.18- 1.25] 1.14 [1.10- 1.19]
Sex: Woman (reference: man) 1.94 [1.23- 3.05] 1.30 [0.82- 2.06]
Poor self-rated health (reference: good) 2.52 [1.43- 4.44]
Number of drugs a 1.17 [1.08- 1.26]
Disability (reference: capable of BADL) 6.58 [3.92- 11.05]
a Quantitative variable. BADL Basic activities of daily living.
Analysis adjusted for:
Model I (age, sex, educational level, socioeconomic level). R2 =0.36.
Model II (age, sex, self-rated health, comorbidity, number of drugs, cognitive decline, physical disability). R2 = 0.45.
The variables not shown in the table were not significantly associated with frailty.
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its relation with frailty, with a higher probability of an
association with frailty at lower walking speeds and a
lower probability with higher walking speeds (Table 3).
Discussion
Frailty as a geriatric syndrome entails an increased risk
of falls, functional decline, hospitalization and death, as
well as greater use of health and social resources
[5,6,31]. Fried’s phenotype, based on the measurement of
five criteria, enjoys broad consensus in the scientific
community. General practitioners who need a simpler
approach to frailty evaluation may find assessment of
the frailty phenotype to be more feasible [15].
The prevalence of frailty in our population according
to Fried’s criteria is around 10.5% in persons age 65 and
older, which is consistent with studies in other Spanish
populations [11-13] as well as large studies in other
countries [7,8]. In our study frailty is more frequent in
women (13.7% versus 6.0%) and occurs at an earlier age
than in men. Women's poorer level of health is largelyTable 3 Distribution of walking speed by different cut-off poi
Walking
speed (m/s)
Total Frail Non fra
N = 1325 N = 148 N = 117
<0.4 136 (10.3%) 86 (58.1%) 50 (4.2%
<0.5 185 (14.0%) 101 (68.2%) 84 (7.1%
<0.6 278 (21.0%) 120 (81.1%) 158 (13.4
<0.7 400 (30.2%) 138 (93.2%) 262 (22.3
<0.8 565 (42.6%) 147 (99.3%) 418 (35.5
<0.9 665 (50.2%) 148 (100.0%) 517 (43.9
<1.0 766 (57.8%) 148 (100.0%) 618 (52.5
<1.1 1001 (75.5%) 148 (100.0%) 853 (72.5
<1.2 1062 (80.2%) 148 (100.0%) 914 (77.7
<1.3 1132 (85.4%) 148 (100.0%) 984 (83.6
<1.4 1178 (88.8%) 148 (100.0%) 1028 (87.
LR+, Likelihood Ratio Positive; LR- Likelihood Ratio negative.
*LR in individuals aged 75 and over.responsible for this: they have greater cognitive decline,
more disability and greater use of drugs, which translates
into higher comorbidity. Women report worse self-rated
health than men, and this parameter is also associated
with frailty [9]. Socioeconomic and health differences
between men and women are becoming narrower with
new generations of older people [29]. However, some
sociodemographic and health characteristics still require
a clinical approach differentiated by sex.
The association of frailty with age has been clearly
established [1,8,11,13,32]. Our study shows an average 14%
increase in the odds of frailty in the population for each
year of life after age 65, resulting in a prevalence of 19% in
those aged 75 and over. The increase is more pronounced
after age 85, 40.2% of whom are frail. This is consistent
with the delayed onset of adverse health events in the geri-
atric population that has been observed based on multiple
health parameters [24]. In any event, consideration of
frailty is important to better reflect biological age [5].
Despite the overlap between frailty, disability and co-
morbidity, they represent distinct domains that are notnts in the cohort
il LR + LR + ≥75* LR
-
LR- ≥75*
7
) 13.83 8.66 0.44 0.44
) 9.60 6.68 0.34 0.34
%) 6.04 4.24 0.22 0.24
%) 4.19 3.00 0.09 0.10
%) 2.80 2.10 0.01 0.01
%) 2.28 1.78 0.00 0.00
%) 1.90 1.56 0.00 0.00
%) 1.38 1.20 0.00 0.00
%) 1.29 1.15 0.00 0.00
%) 1.20 1.10 0.00 0.00
3%) 1.14 1.07 0.00 0.00
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often associated, but the detection of frailty has an import-
ant impact on care in the last stage of life, precisely be-
cause it does not focus on the diagnosis of illnesses [15].
Early diagnosis of frailty in primary care is an import-
ant goal – first, because of its high prevalence, which is
likely to rise even further in the future [16], second, be-
cause of its prognostic value, given these individuals'
greater risk of presenting functional impairment or ad-
verse health events [11-16], and finally, because there
are possible treatments that can delay or even reverse
frailty in its early stages, before the onset of physical
and/or mental disability [15,24]. When clinicians are
considering any changes in patient care, including a new
medication, they should not only evaluate the patient’s
morbidity, but should also take into account the individ-
ual's degree of frailty and the extent to which the inter-
vention may affect the prognosis [3].
However, diagnosis of the frailty phenotype in daily
practice has some drawbacks since the original cut-off
points for some criteria cannot always be extrapolated to
different populations [11,13,32]; moreover, it is based on
a combination of five tests, which require instruments
and take over 10 minutes to perform [16]. Thus, a test
that is easy to perform and is highly related to frailty
may be of interest. Walking speed is a simple, quick, and
easily performed test [19]. It is widely used in com-
prehensive geriatric assessment [23] and, unlike Fried's
slowness criterion, does not require adjustment for ei-
ther sex or height. Some investigators have found that
walking speed alone is a health indicator that is particu-
larly informative after age 75 years [20] and is predictive
of frailty and adverse outcomes [5,7].
In our study, frailty in individuals aged 65–74 years is
very low (around 1.4%) and increases among those agedPERSONS ≥ 65 YEARS
FRAILTY 10.4%
NO (21.4%)
FRAILTY 0.3%
NO (48.5%)
FRAILTY 1.4%
PERSONS≥ 
75 YEARS
(*) The proportions of population and frailty are calculated using
weighted data by age and sex for the reference population 
Figure 2 Proposed algorithm for diagnosis of frailty in primary care b75 and over to 19%. Based on these data, exploration of
the five items that make up the frailty syndrome in all
persons aged 75 and over would result in a diagnosis of
frailty in one of every five individuals examined. Such an
effort would involve a heavy burden of work given the
large number of persons targeted.
The cut-off point to identify persons with slow walking
speed is a subject of debate; the most frequently employed
cut-offs are 1 m/s and 0.8 m/s [20-23]. In our analysis of
multiple cut-off points (between 0.4 and 1.4 m/s) we
found that between 0.8 and 0.9 m/s is the most useful cut-
off above which frailty can be ruled out. The prevalence
results found in those cut-off points, as well as the LR +
and LR-, which are shown in Table 3, and the fact that
0.8 m/s has been proposed by different authors [22,23] in-
clines us to choose that cut-off point as the one most
closely related to the diagnosis of frailty.
In this context, and based on our results, we propose a
simple approach to the diagnostic process in the primary
care setting. Figure 2 shows an algorithm for action
based on the distribution of the elderly population, the
estimation of the prevalence of frailty in the different
study groups, and the capacity of slow walking speed to
predict the presence of frailty.
A critical aspect with respect to implementation of this
measure in primary care is the applicability of the test;
its reproducibility must be assured. Typically, it is mea-
sured over a distance of 5 m, although it may need to be
adapted in primary care consultations to 3 or 4 meters,
depending on space availability [5,33].
With regard to the study limitations, aside from those
characteristic of any cross-sectional study, it should be
taken into account that many of the variables used were
self-reported, although frailty was measured based on an
objective test performed by health personnel. The factYES (30.1%)
FRAILTY 32.1%
FRAILTY 
SCREENING
(5 criteria)
YES (51.5% ) 
FRAILTY 19%
 the study results and 
WALKING 
SPEED
<0’8m/s
ased on age and walking speed.
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http://www.biomedcentral.com/1471-2296/14/86that the study was conducted in a large population-
based cohort (1,327 participants) representative of the
older population in an urban area supports the strength
of the results. It should be noted that our work was not
meant to be a validation study, since the two indicators
compared were measured at the same time and in the
same population. The LR was chosen to overcome this
weakness in the field work design. As noted by Fletcher
and Fletcher, the likelihood ratio, in this context, con-
tains information similar to sensitivity and specificity
without the design of a validation study [30].Conclusions
Persons aged 75 years and over have a high prevalence
of frailty, which reached 19% in our study. Early diagno-
sis of frailty by the family physician has clear impli-
cations for improving health given the possibility of
reversing the process and preventing adverse events in
the elderly. However, exploration of Fried’s five criteria
requires use of a substantial amount of resources in pri-
mary care.
Measurement of walking speed is a simple, quick, and
easily performed test that is a good indicator of health and
survival in older adults, especially after age 75. Our data
confirm that a walking speed of ≥0.9 m/s rules out the
presence of frailty, and that a walking speed of ≤0.8 m/s
doubles the probability of a diagnosis of frailty. Accord-
ingly, we propose that the first step in frailty detection
should be measurement of walking speed in all persons
aged 75 and over in the family physician’s daily clinical
practice, using a cut-off point of 0.8 m/s. A standardized
methodology must be used to ensure reproducibility.Ethical approval
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